Back to search

Azadyne Ltd

11740078

active
Private Limited Company
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

101 NEW CAVENDISH STREET, LONDON, W1W 6XH
Incorporated 24/12/2018

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Jason Edward Rutt

director · Since 24/12/2018

DIRECTOR

BRITISH · ENGLAND · Age 54

Also on 2 other boards

Dr Stephen Joseph Connon

director · Since 21/02/2019

ACADEMIC

IRISH · IRELAND · Age 50

Mr Jonathan Stuart Synett

director · Since 13/05/2019

COMPANY DIRECTOR

BRITISH · ENGLAND · Age 49

Also on 15 other boards

Mr Paul Michael Tselentis

director · Since 10/11/2022

CHIEF EXECUTIVE OFFICER

BRITISH,GREEK,SOUTH AFRICAN · ENGLAND · Age 45

Also on 3 other boards

Persons with Significant Control

Mr Jason Edward Rutt

Appoint directors

British · England · Age 54

101, New Cavendish Street, London, W1W 6XH

Notified 23/12/2019

Former PSCs

Mr Vincent Patrick Kelly

Ceased 20/02/2019

Mr John Michael Southern

Ceased 20/02/2019

Mr Stephen Joseph Cannon

Ceased 20/02/2019

CompanyRankvs 2370+ SIC 72110 peers
77

Financial strength92th percentile among SIC peers · 23/25
Employees77th percentile among SIC peers · 12/15
LiquidityCurrent ratio 14.27× · 20/20
Longevity7 years trading (max 15) · 7/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Labgenius Limited
89
9Nuclera Ltd
88
10Aparito Limited
87
237Azadyne Ltd
77
How is this score calculated?
Financial strength23/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees12/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity7/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

£939k

Balance sheet strength

Cash

£537k

Cash in the bank

Net Current Assets

£644k

Working capital

Current Assets

£693k

Current Liabilities

£49k

Fixed Assets

£295k

Debtors

£155k

3avg. employees-3

Balance Sheet

Intangible assets£294k
Assets less current liabilities£939k
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearCurrent RatioImplied Profit
202414.27+£592
20234.57-£1.0M
202214.00+£1.6M
20215.76-£287k
202014.22+£452k
201912.91—

Derived from filed accounts. Not audited figures.